Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 29 |
| Active Pipeline (Recruiting Now) | 10 (10) |
| Completed vs Stopped Early | 16 / 2 (6.9%) |
| Median Closed Actual Enrollment | 242 participants |
| Physical Hospital Site Disclosure | 1.5% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Explore interactive annual charts and M&A subsidiary rollups in the Axsome Therapeutics Interactive Dossier, benchmark peers in Neurology, Psychiatry, and Pain, or review the Healthcare Price & Patent Cliff Crosswalk.